At Mount Sinai, researchers are exploring other approaches: One is changing the peanut proteins themselves for use in immunotherapy, with the goal of diminishing the risk of the adverse reaction during the treatment, Nowak-Wegrzyn said.

CNN: 'Exciting' advance reported in peanut allergy therapy